ULRR
metadata only
CC BY-NC-SA 4.0
Pancreatic and gallbladder adverse events associated with tirzepatide in obesity management: a scoping review
Peer-reviewed
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Tirzepatide and Muscle Outcomes in Obesity#253177
- Real-world Effectiveness and Dosing Patterns of Tirzepatide in People With Obesity#353386
- A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight for the Maintenance of Weight Loss#424333
- A Study of Tirzepatide (LY3298176) Once Weekly in Adolescent Participants Who Have Obesity or Overweight With Weight-Related Comorbidities#279647
- A Study of Tirzepatide in Overweight and Very Overweight Participants#1370251
Record · ID 1570437
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive